It would seem that the -glutamyl cysteine should instead add a glycine molecule (glutathione synthetase reaction) (Figure 2, reaction 5) and thereby replenish glutathione
SGLT2-i reduces both systolic blood pressure (SBP) and diastolic blood pressure (DBP) across multiple trials and meta-analyses with reductions up to 8.6/4.3 mmHg, depending on the agent, dose and population studied
Sarna, S., Sipil, I., Rnnholm, K., Koistinen, R
Theyre small enough for your body to absorb easily
In a placebo-controlled clinical trial , glutathione IV therapy showcased mild improvements with tremors and rigidness, potentially improving the quality of life in those suffering from this disease